These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 139855)

  • 1. Studies of urticaria and acute serum sickness with the C1q precipitin test.
    Lieberman P; Rice MC; Mallette JE
    Arch Intern Med; 1977 Apr; 137(4):440-2. PubMed ID: 139855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement component analysis in angiodema. Diagnostic value.
    Brasher GW; Starr JC; Hall FF; Spiekerman AM
    Arch Dermatol; 1975 Sep; 111(9):1140-2. PubMed ID: 1167046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 4. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hepatitis: significance of changes in complement components.
    Charlesworth JA; Lawrence S; Worsdall PA; Roy LP; Boughton CR
    Clin Exp Immunol; 1977 Jun; 28(3):496-501. PubMed ID: 891025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human serum sickness.
    Lawley TJ; Bielory L; Gascon P; Yancey KB; Young NS; Frank MM
    Trans Assoc Am Physicians; 1984; 97():49-55. PubMed ID: 6336015
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactivity to autologous serum skin test and relationship with complement levels in chronic idiopathic urticaria and angio-oedema.
    Zamiri M; Jury CS; Dawe RS; O'Neill S; Douglas WS
    Clin Exp Dermatol; 2009 Jul; 34(5):587-90. PubMed ID: 19094131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune complex and complement levels in spontaneous abortions and normal pregnancy].
    Saitoh S; Nakanishi A; Ichijo M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1981-90. PubMed ID: 6607297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data].
    Schena FP; Pertosa G; Manno C; Losuriello V; Pastore A
    Minerva Chir; 1980 May; 35(10):709-14. PubMed ID: 7005726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complement. Evaluation of some complement fractions in patients affected by neoplasia undergoing chemotherapy (author's transl)].
    Ignesti C; Lenzi L; Salvadori D; Innocenti V; Baroncelli C; Casadei BM
    Quad Sclavo Diagn; 1981 Jun; 17(2):152-6. PubMed ID: 6943601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes and the complements system in lupus nephropathy.
    Serban MG
    Rom J Intern Med; 1992; 30(2):119-25. PubMed ID: 1496264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of C1 subcomponents in chronic urticaria and angioedema.
    Laurell AB; Mårtensson U; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1977; 54(5):434-42. PubMed ID: 885628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies].
    Sobel A; Gabay Y; Lagrue G
    Nouv Presse Med; 1976 Jun; 5(23):1465-9. PubMed ID: 132639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.